Producing life-saving medicines in a way that is environmentally sustainable by implementing green chemistry and engineering has been the focus of the ACS GCI Pharmaceutical Roundtable (ACS GCIPR) since its inception in 2005. Investing in green chemistry has brought substantial benefits, both environmental and economic, and solidified green chemistry across the industry as the gold standard.
moreBy Vittoria Valentine, Program Specialist, ACS Green Chemistry Institute
The ACS GCI Pharmaceutical Roundtable (GCIPR) is pleased to announce the recipients of the 2025 Industry Awards. These awards honor advancements in green chemistry within the pharmac
... moreEight researchers from the United States, Canada, and Europe have been awarded research grant funding totaling $480,000 from the ACS Green Chemistry Institute Pharmaceutical Roundt